The Clinical Trial Exceptional Service Award also was presented to Lacey Angioletti, a patient who participated in the clinical trials of the life-saving treatment Coreg. Angioletti was only 21-years old when she was diagnosed with heart failure. Now at age 34, Angioletti is an actress and thankfully leading a healthy life, due in large part, to this prescription medicine.
PhRMA's President and CEO Billy Tauzin, in his remarks at the press conference said, "The recipients of these Awards should all be proud that they played such an incredible role in advancing health care here in America and around the world. Millions of patients worldwide now live healthier, longer lives because of the critical research that was done by these dedicated researchers." Tauzin added, "These extraordinary honorees certainly deserve this recognition because they are the heroes behind the miracle medicine that has helped patients like Lacey win their battle against life-threatening heart diseases."
Alan Metz, M.D., GlaxoSmithKline's Vice President and Medical Director,
North America, added that, "Coreg is a wonderful example of how creative
science can change the fundamental thinking about the way we treat disease,
and how innovation can make a life-saving difference to patients. The
scientists we honor today championed this achievement, and hundreds of
others in GSK shared their vision and passion to make this medicine a
|SOURCE Pharmaceutical Research and Manufacturers of America|
Copyright©2008 PR Newswire.
All rights reserved